These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
267 related articles for article (PubMed ID: 34893244)
1. pH-Sensitive nanoparticles based on amphiphilic imidazole/cholesterol modified hydroxyethyl starch for tumor chemotherapy. Xu Z; Yang D; Long T; Yuan L; Qiu S; Li D; Mu C; Ge L Carbohydr Polym; 2022 Feb; 277():118827. PubMed ID: 34893244 [TBL] [Abstract][Full Text] [Related]
2. Doxorubicin-Bound Hydroxyethyl Starch Conjugate Nanoparticles with pH/Redox Responsive Linkage for Enhancing Antitumor Therapy. Tan R; Tian D; Liu J; Wang C; Wan Y Int J Nanomedicine; 2021; 16():4527-4544. PubMed ID: 34276212 [TBL] [Abstract][Full Text] [Related]
3. pH-sensitive small molecule nanodrug self-assembled from amphiphilic vitamin B6-E analogue conjugate for targeted synergistic cancer therapy. Yan G; Chen R; Xiong N; Song J; Wang X; Tang R Colloids Surf B Biointerfaces; 2020 Jul; 191():111000. PubMed ID: 32247946 [TBL] [Abstract][Full Text] [Related]
4. PEGylated and poloxamer-modified chitosan nanoparticles incorporating a lysine-based surfactant for pH-triggered doxorubicin release. Scheeren LE; Nogueira DR; Macedo LB; Vinardell MP; Mitjans M; Infante MR; Rolim CM Colloids Surf B Biointerfaces; 2016 Feb; 138():117-27. PubMed ID: 26674840 [TBL] [Abstract][Full Text] [Related]
6. H Liang YX; Sun XY; Xu DZ; Huang JR; Tang Q; Lu ZL; Liu R Bioorg Chem; 2022 Feb; 119():105559. PubMed ID: 34952244 [TBL] [Abstract][Full Text] [Related]
7. Enzyme-Induced Transformable Peptide Nanocarriers with Enhanced Drug Permeability and Retention to Improve Tumor Nanotherapy Efficacy. Gong Z; Zhou B; Liu X; Cao J; Hong Z; Wang J; Sun X; Yuan X; Tan H; Ji H; Bai J ACS Appl Mater Interfaces; 2021 Dec; 13(47):55913-55927. PubMed ID: 34784165 [TBL] [Abstract][Full Text] [Related]
8. MRI-visible and pH-sensitive micelles loaded with doxorubicin for hepatoma treatment. Li B; Cai M; Lin L; Sun W; Zhou Z; Wang S; Wang Y; Zhu K; Shuai X Biomater Sci; 2019 Mar; 7(4):1529-1542. PubMed ID: 30681081 [TBL] [Abstract][Full Text] [Related]
9. PEGylated Poly(α-lipoic acid) Loaded with Doxorubicin as a pH and Reduction Dual Responsive Nanomedicine for Breast Cancer Therapy. Yang H; Shen W; Liu W; Chen L; Zhang P; Xiao C; Chen X Biomacromolecules; 2018 Nov; 19(11):4492-4503. PubMed ID: 30346147 [TBL] [Abstract][Full Text] [Related]
10. Conjugated Polymer Nanoparticles Based on Copper Coordination for Real-Time Monitoring of pH-Responsive Drug Delivery. Li J; Du N; Tan Y; Hsu HY; Tan C; Jiang Y ACS Appl Bio Mater; 2021 Mar; 4(3):2583-2590. PubMed ID: 35014375 [TBL] [Abstract][Full Text] [Related]
11. Enzyme and Thermal Dual Responsive Amphiphilic Polymer Core-Shell Nanoparticle for Doxorubicin Delivery to Cancer Cells. Kashyap S; Singh N; Surnar B; Jayakannan M Biomacromolecules; 2016 Jan; 17(1):384-98. PubMed ID: 26652038 [TBL] [Abstract][Full Text] [Related]
12. Self-Assembled Cationic Biodegradable Nanoparticles from pH-Responsive Amino-Acid-Based Poly(Ester Urea Urethane)s and Their Application As a Drug Delivery Vehicle. He M; Potuck A; Kohn JC; Fung K; Reinhart-King CA; Chu CC Biomacromolecules; 2016 Feb; 17(2):523-37. PubMed ID: 26650653 [TBL] [Abstract][Full Text] [Related]
13. Microfluidics-Assisted Surface Trifunctionalization of a Zeolitic Imidazolate Framework Nanocarrier for Targeted and Controllable Multitherapies of Tumors. Shen J; Ma M; Zhang H; Yu H; Xue F; Hao N; Chen H ACS Appl Mater Interfaces; 2020 Oct; 12(41):45838-45849. PubMed ID: 32956582 [TBL] [Abstract][Full Text] [Related]
14. Doxorubicin-Loaded Carbon Dots Lipid-Coated Calcium Phosphate Nanoparticles for Visual Targeted Delivery and Therapy of Tumor. Zhang J; Zhang H; Jiang J; Cui N; Xue X; Wang T; Wang X; He Y; Wang D Int J Nanomedicine; 2020; 15():433-444. PubMed ID: 32021189 [TBL] [Abstract][Full Text] [Related]
15. Indocyanine green/doxorubicin-encapsulated functionalized nanoparticles for effective combination therapy against human MDR breast cancer. Chen HH; Lu IL; Liu TI; Tsai YC; Chiang WH; Lin SC; Chiu HC Colloids Surf B Biointerfaces; 2019 May; 177():294-305. PubMed ID: 30771581 [TBL] [Abstract][Full Text] [Related]
16. pH-Driven Targeting Nanoprobe with Dual-Responsive Drug Release for Persistent Luminescence Imaging and Chemotherapy of Tumor. Zhang HJ; Zhao X; Chen LJ; Yang CX; Yan XP Anal Chem; 2020 Jan; 92(1):1179-1188. PubMed ID: 31818096 [TBL] [Abstract][Full Text] [Related]
17. Chitosan-based DDSs for pH/hypoxia dual-triggered DOX delivery: Facile morphology modulation for higher in vitro cytotoxicity. Xie P; Liu P Carbohydr Polym; 2022 Jan; 275():118760. PubMed ID: 34742449 [TBL] [Abstract][Full Text] [Related]
18. Multistage pH-responsive mesoporous silica nanohybrids with charge reversal and intracellular release for efficient anticancer drug delivery. Yuan X; Peng S; Lin W; Wang J; Zhang L J Colloid Interface Sci; 2019 Nov; 555():82-93. PubMed ID: 31377647 [TBL] [Abstract][Full Text] [Related]
19. Fabrication of doxorubicin nanoparticles by controlled antisolvent precipitation for enhanced intracellular delivery. Tam YT; To KK; Chow AH Colloids Surf B Biointerfaces; 2016 Mar; 139():249-58. PubMed ID: 26724466 [TBL] [Abstract][Full Text] [Related]
20. Human serum albumin-based doxorubicin prodrug nanoparticles with tumor pH-responsive aggregation-enhanced retention and reduced cardiotoxicity. Zhang B; Wan S; Peng X; Zhao M; Li S; Pu Y; He B J Mater Chem B; 2020 May; 8(17):3939-3948. PubMed ID: 32236239 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]